Surface coating of PLGA microparticles with protamine enhances their immunological performance through facilitated phagocytosis

被引:61
作者
Gomez, Julia M. Martinez [1 ]
Csaba, Noemi [2 ]
Fischer, Stefan [2 ]
Sichelstiel, Anke [1 ]
Kuendig, Thomas M. [1 ]
Gander, Bruno [2 ]
Johansen, Pal [1 ]
机构
[1] Univ Zurich Hosp, Dept Dermatol, Unit Expt Immunotherapy, CH-8091 Zurich, Switzerland
[2] ETH, Inst Pharmaceut Sci, CH-8093 Zurich, Switzerland
关键词
microparticles; protamine; transfection; uptake; immune response;
D O I
10.1016/j.jconrel.2008.06.003
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Surface modifications of poly(lactide-co-glycolide) microparticles with different polycationic electrolytes have mainly been studied for conjugation to antigens and/or adjuvants. However, the in vivo immunological effects of using surface charged particles have not been address yet. In this study, microparticles were coated or not with protamine, a cationic and arginine-rich electrolyte that confers microparticles with a positively surface charge. We then evaluated the potential of protamine-coatings to assist the induction of immune responses in mice. Interestingly, enhanced antibodies and T-cell responses were observed in mice treated with the coated particles. In vitro studies suggested that the improved immunological performance was mediated by an increased uptake. Indeed, protamine-coated particles that carried a plasmid were even internalised into non-phagocytic cells and to cause their transfection. These results open the way for further research into a novel technology that combines the use protamine for facilitated cell penetration of that and biodegradable microparticles for prolonged antigen or drug release. (C) 2008 Published by Elsevier B.V.
引用
收藏
页码:161 / 167
页数:7
相关论文
共 51 条
[1]  
Ahmad-Nejad P, 2002, EUR J IMMUNOL, V32, P1958, DOI 10.1002/1521-4141(200207)32:7<1958::AID-IMMU1958>3.0.CO
[2]  
2-U
[3]   Surfactant-free anionic PLA nanoparticles coated with HIV-1 p24 protein induced enhanced cellular and humoral immune responses in various animal models [J].
Ataman-Onal, Yasemin ;
Munier, Severine ;
Ganee, Arnaud ;
Terrat, Celine ;
Durand, Pierre-Yves ;
Battail, Nicole ;
Martinon, Frederic ;
Le Grand, Roger ;
Charles, Marie-Helene ;
Delair, Thierry ;
Verrier, Bernard .
JOURNAL OF CONTROLLED RELEASE, 2006, 112 (02) :175-185
[4]   The protamine family of sperm nuclear proteins [J].
Balhorn, Rod .
GENOME BIOLOGY, 2007, 8 (09)
[5]   Defective TCR expression in transgenic mice constructed using cDNA-based α- and β-chain genes under the control of heterologous regulatory elements [J].
Barnden, MJ ;
Allison, J ;
Heath, WR ;
Carbone, FR .
IMMUNOLOGY AND CELL BIOLOGY, 1998, 76 (01) :34-40
[6]  
BRANGE J, 1992, ACTA PHARM NORDICA, V4, P149
[7]  
Brange J, 1997, Pharm Biotechnol, V10, P343
[8]   Tat peptide-mediated cellular delivery:: back to basics [J].
Brooks, H ;
Lebleu, B ;
Vivès, E .
ADVANCED DRUG DELIVERY REVIEWS, 2005, 57 (04) :559-577
[9]   Low molecular weight protamine: A potent but nontoxic antagonist to heparin/low molecular weight protamine [J].
Byun, Y ;
Chang, LC ;
Lee, LM ;
Han, IS ;
Singh, VK ;
Yang, VC .
ASAIO JOURNAL, 2000, 46 (04) :435-439
[10]   Nuclear localisation and pDNA condensation in non-viral gene delivery [J].
Collins, Elizabeth ;
Birchall, James C. ;
Williams, Julie L. ;
Gumbleton, Mark .
JOURNAL OF GENE MEDICINE, 2007, 9 (04) :265-274